Innoviva, Inc.
(NASDAQ : INVA)

( )
INVA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
ICPTIntercept Pharmaceuticals, Inc.
-7.27%91.8318.6%$115.61m
AMRNAmarin Corporation Plc Sponsored ADR
1.34%17.432.0%$110.08m
SAGESAGE Therapeutics, Inc.
-1.00%146.189.5%$75.87m
JAZZJazz Pharmaceuticals Plc
-1.24%125.212.2%$72.29m
PRGOPerrigo Co. Plc
-1.29%48.316.8%$61.64m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-1.32%143.956.3%$58.83m
CTLTCatalent Inc
-0.54%42.562.4%$43.41m
PTLAPortola Pharmaceuticals, Inc.
0.67%30.157.7%$42.79m
ICLRICON Plc
-2.58%142.154.1%$34.10m
UTHRUnited Therapeutics Corporation
-0.74%117.0214.4%$30.49m
HZNPHorizon Pharma plc
-1.39%21.247.4%$29.47m
CORTCorcept Therapeutics Incorporated.
-2.03%11.095.5%$29.29m
MDCOMedicines Company
0.04%23.9021.8%$27.19m
AERIAerie Pharmaceuticals, Inc.
-2.30%38.706.9%$25.97m
IRWDIronwood Pharmaceuticals, Inc. Class A
-0.84%14.1810.1%$24.42m

Company Profile

Innoviva, Inc. engages in the development, commercialization, and financial management of bio-pharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate; and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Brisbane, CA.